[Federal Register: August 31, 2004 (Volume 69, Number 168)]
[Page 53078-53079]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Veterinary Medicine Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Veterinary Medicine Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on October 13, 2004, from 
8:30 a.m. to 5 p.m.
    Location: DoubleTree Hotel, Plaza III, 1750 Rockville Pike, 
Rockville, MD.
    Contact Person: Aleta Sindelar, Center for Veterinary Medicine 
(HFV-3), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 
20855, 301-827-4515, e-mail: asindela@cvm.fda.gov, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512548, for up-to-date information on 
this meeting.
    Agenda: The committee will discuss and make recommendations on the 
microbial food safety of an antimicrobial drug application currently 
under review for use in food-producing animals in accordance with the 
Center for Veterinary Medicine's guidance for industry 152.
    The background material for this meeting will be posted on the 
Internet no later than 1 business day before the meeting athttp://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/cvm/default.html.
 A limited number of paper copies of the 

background information will be available at the registration table.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by October 1, 
2004. Oral presentations from the public will be scheduled between 
approximately 10:45 a.m. and 11:45 a.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person by October 1, 2004, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of

[[Page 53079]]

proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Aleta Sindelar at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 24, 2004.
Lester M. Crawford,
Acting Commissioner for Food and Drugs.
[FR Doc. 04-19779 Filed 8-30-04; 8:45 am]